SLC2A1 and colorectal cancer: In addition to its potential to curtail glucose uptake in colon cancer cells and attenuate the transcription of glucose metabolism-related genes (GLUT1, LDHA, and HK2), berberine be identified its potential by suppressing mTOR-dependent HIF1α protein synthesis, thus inhibiting heightened glucose metabolism in colorectal cancer cells [156].